These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 8359082)
1. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis. Henriksson K; Uribe A; Sandstedt B; Nord CE Dig Dis Sci; 1993 Sep; 38(9):1688-96. PubMed ID: 8359082 [TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
3. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers. Ballinger A Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123 [TBL] [Abstract][Full Text] [Related]
4. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
5. Changes in Helicobacter pylori status in patients with rheumatoid arthritis under non-steroidal anti-inflammatory drugs. Moriyama T; Matsumoto T; Fuchigami T; Nakamura S; Ishikawa N; Takubo N; Yamamoto S; Oshiro Y; Nakanishi M; Tomioka K; Iida M Scand J Gastroenterol; 2004 Feb; 39(2):111-8. PubMed ID: 15000271 [TBL] [Abstract][Full Text] [Related]
6. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs. Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813 [TBL] [Abstract][Full Text] [Related]
7. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis. Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504 [TBL] [Abstract][Full Text] [Related]
8. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180 [TBL] [Abstract][Full Text] [Related]
9. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events. Frezza M; Gorji N; Melato M J Clin Pathol; 2001 Jul; 54(7):521-5. PubMed ID: 11429423 [TBL] [Abstract][Full Text] [Related]
10. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Loeb DS; Talley NJ; Ahlquist DA; Carpenter HA; Zinsmeister AR Gastroenterology; 1992 Jun; 102(6):1899-905. PubMed ID: 1587409 [TBL] [Abstract][Full Text] [Related]
11. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management. Chan FK Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239 [TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715 [TBL] [Abstract][Full Text] [Related]
14. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users. Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954 [TBL] [Abstract][Full Text] [Related]
15. Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study. Shah K; Price AB; Talbot IC; Bardhan KD; Fenn CG; Bjarnason I Gut; 1995 Aug; 37(2):195-8. PubMed ID: 7557567 [TBL] [Abstract][Full Text] [Related]
16. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953 [TBL] [Abstract][Full Text] [Related]
17. Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs. Chandrasekaran AN; Sambandam PR; Lal HM; Ramakrishnan S; Porkodi R; Krishnamurthy V; Achutan K J Assoc Physicians India; 1991 Dec; 39(12):919-21. PubMed ID: 1816217 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Voutilainen M; Sokka T; Juhola M; Farkkilä M; Hannonen P Scand J Gastroenterol; 1998 Aug; 33(8):811-6. PubMed ID: 9754727 [TBL] [Abstract][Full Text] [Related]
19. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Labenz J; Blum AL; Bolten WW; Dragosics B; Rösch W; Stolte M; Koelz HR Gut; 2002 Sep; 51(3):329-35. PubMed ID: 12171952 [TBL] [Abstract][Full Text] [Related]